Results 71 to 80 of about 9,058 (209)

Development and preliminary validation of a new screening questionnaire for identifying atopic children [PDF]

, 2017
Background: Allergic diseases represent a frequent and increasing condition affecting children. A screening questionnaire allowing an easy identification of children with symptoms of allergic diseases may improve management and clinical outcome.
BRUSCOLINI, ALICE, Ilaria, Baiardini, LAMBIASE, ALESSANDRO, Loredana, Chini, SACCHETTI, MARTA, Viviana, Moschese   +5 more
core   +1 more source

Vocal biomarkers correlate with FEV1 variations during methacholine challenge

Clinical and Translational Allergy, Volume 15, Issue 4, April 2025.
Abstract Background Mobile health applications are increasingly valued for their role in asthma management and the opportunity for large dataset collection. Our study aimed to investigate the feasibility of applying signal‐processing and machine‐learning technologies to detect alterations in the lower airway caliber and develop a machine‐learning ...
Giovanni Paoletti, Giovanni Costanzo, Morena Merigo, Francesca Puggioni, Sebastian Ferri, Maria Rita Messina, Fulvio Cordella, Giuseppe Ranieri, Arianna Arienzo, Victor Savevski, Giorgio Walter Canonica, Ayana de Brito Martins, Enrico Heffler   +12 more
wiley   +1 more source

Omalizumab reduces anaphylactic reactions and allows food introduction in food‐allergic in children with severe asthma: An observational study

Allergy, Volume 80, Issue 4, Page 1074-1085, April 2025.
In Europe, Omalizumab is indicated for the treatment of moderate to severe asthma, but not for IgE‐mediated food allergy. We assessed the impact of Omalizumab on efficacy, safety, and the quality of life (FA‐QoL) in patients with moderate to severe asthma and who have a history of anaphylaxis to peanut, tree nuts, fish, egg, milk, and/or wheat.
Stefania Arasi, Arianna Cafarotti, Francesca Galletta, Valentina Panetta, Carla Riccardi, Veronica Calandrelli, Vincenzo Fierro, Lamia Dahdah, Maria Cristina Artesani, Rocco Luigi Valluzzi, Valentina Pecora, Valeria Tallarico, Giulio Dinardo, Lucia Lo Scalzo, Alessandro Fiocchi   +14 more
wiley   +1 more source

A Single Multiplex CytoBas Assay Incorporating Eight Major Components for Accurate Detection of Allergen Sensitization in Asthma and Allergic Rhinitis

Allergy, Volume 80, Issue 4, Page 1047-1059, April 2025.
Combined evaluation of 8 aeroallergen components in a single flow cytometry assay can differentially detect house dust mite, grass pollen, cat, and dog sensitization on blood basophils (AeroDiff CytoBas). The AeroDiff CytoBas assay demonstrated similar to superior diagnostic accuracy compared to singleplex component‐specific IgE serology.
Lin Hsin, Mark Hew, Pei Mun Aui, Kirsten Deckert, P. Mark Hogarth, Robyn E. O'Hehir, Menno C. van Zelm   +6 more
wiley   +1 more source

Determination of the Bioavailability of 3 Intranasal Formulations of Azelastine Hydrochloride in Healthy Male Volunteers

Clinical Pharmacology in Drug Development, Volume 14, Issue 3, Page 217-222, March 2025.
Abstract The primary objective of the study was to determine the bioavailability of 2 new formulations of azelastine (AZE) hydrochloride (0.10% and 0.15% AZE) containing sorbitol and sucralose compared with the commercially available 0.10% AZE. This study was performed in healthy volunteers based on the pharmacokinetic parameters maximum plasma ...
Jean Bousquet, Ludger Klimek, Mark Liu, Duc Tung Nguyen, Rajesh Kumar Ramalingam, Georgio Walter Canonica, William E. Berger   +6 more
wiley   +1 more source

One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable

Allergy, Volume 80, Issue 3, Page 807-816, March 2025.
This study evaluated safety and tolerability of house dust mite SCIT during dose escalation with a new one‐strength regimen (6 injections, strength 3) compared to the standard regimen (14 injections, strengths 1–3) in adults and adolescents. Safety and tolerability were comparable between the two regimens, adults and adolescents, as well as asthmatics,
M. Jutel, C. Vogelberg, K. Duwensee, D. Troyke, L. Klimek   +4 more
wiley   +1 more source

Evaluation of SubcutaneousRush Immunotherapy Effectiveness in Perennial Allergic Rhinitis after a Year from Treatment [PDF]

Iranian Journal of Otorhinolaryngology, 2019
Introduction: Allergen immunotherapy is an effective treatment for allergic rhinitis. Conventional immunotherapy takesat least 5 to 6 months to reach the maintenance dosage; nonetheless, rush immunotherapy accelerates to reach the maintenance dose ...
Mohsen Tizro, Reza Farid Hosseini, Maryam Khoshkhui, Ali Fouladvand, Mojgan Mohamadi, Samane Sistani, Farahzad Jabbari Azad   +6 more
doaj   +1 more source

Optimal management of allergic rhinitis [PDF]

, 2015
Allergic rhinitis (AR), the most common chronic disease in childhood is often ignored, misdiagnosed and/or mistreated. Undertreated AR impairs quality of life, exacerbates asthma and is a major factor in asthma development. It can involve the nose itself,
Scadding, GK
core   +1 more source

Pollen respiratory allergy: Is it really seasonal?

World Allergy Organization Journal, 2023
Allergic rhinitis (AR) is a highly prevalent respiratory condition that carries a heavy burden and can have a significant impact on patient quality of life.
Gennaro D'Amato, MD, Margarita Murrieta-Aguttes, MD, Maria D'Amato, MD, Ignacio Javier Ansotegui, MD, PhD   +3 more
doaj  

A modern approach to the comprehensive treatment of allergic rhinitis

Медицинский совет, 2019
The problem of allergic rhinosinusopathies is one of the most pressing in modern rhinology. It has drawn the attention of clinicians for several decades. Allergic rhinitis is a common disease, the onset of which often come in early childhood.
S. A. Karpishchenko, G. V. Lavrenova, A. S. Mil’chakova   +2 more
doaj   +1 more source